EUVIMEDEUVIMED entdecken
Crossref

A plant alkaloid lycorine inhibits non-small cell lung cancer cell proliferation, metastasis, glycolysis and promotes ferroptosis through the ZNF143/SPC25 axis

Meng Lv, Xiangrui Chen, Yaqiong Wang, Qiting Yang, Yongbiao Lv, Wei Xie, Junxiang Cai

Journal of Natural Medicines · 2026-05 · 80 (3) · 530-540

DOI: 10.1007/s11418-025-01966-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Natural Medicines, online erschienen am 09.03.2026. Verfasst von Meng Lv und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Shenzhen Hospital of Traditional Chinese Medicine, Shenzhen, China. Hauptthemen laut MEDLINE: Amaryllidaceae Alkaloids, Phenanthridines, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Sanming Project of Medicine in Shenzhen, "Zhaoyang Talents Project" of Guangdong Provincial Hospital of Chinese Medicine, “Zhaoyang Talents Project” of Guangdong Provincial Hospital of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lycorine has been shown to have anti-tumor activity in many cancers, including non-small cell lung cancer (NSCLC). However, its underlying molecular mechanisms still need to be further revealed. The expression levels of spindle component 25 (SPC25) and zinc finger protein 143 (ZNF143) were examined by qRT-PCR and western blot. Cell proliferation, migration and invasion were determined by colony formation assay and transwell assay. Glucose uptake, lactate production and ATP level were evaluated to assess cell glycolysis. The levels of ROS, MDA, GSH and Fe2+ were examined to evaluate ferroptosis. Animal experiments were performed to explore the role of SPC25 and lycorine in vivo. The interaction between ZNF143 and SPC25 promoter was confirmed by ChIP and dual-luciferase reporter assays. SPC25 was overexpressed in NSCLC tissues and cells. Lycorine could reduce SPC25 expression. SPC25 overexpression promoted NSCLC cell proliferation, metastasis, glycolysis, suppressed ferroptosis, and enhanced tumorigenesis, while lycorine reversed these effects. ZNF143 could bind to SPC25 promoter region to increase its expression. SPC25 knockdown reversed the promoting effect of ZNF143 on NSCLC cell proliferation, metastasis and glycolysis, as well as the inhibitory effect on ferroptosis, and these effects could be aggravated by lycorine. In conclusion, lycorine may suppress ZNF143/SPC25 axis to inhibit NSCLC malignant progression, providing new evidence that lycorine can be used as an adjuvant therapy for NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amaryllidaceae AlkaloidsPhenanthridinesCarcinoma, Non-Small-Cell LungLung NeoplasmsFerroptosisHumansCell ProliferationGlycolysisAnimalsCell Line, TumorMiceMice, NudeTrans-Activators

Stichwörter der Autor:innen

LycorineNon-small cell lung cancerSPC25ZNF143

Substanzen

Amaryllidaceae AlkaloidslycorinePhenanthridinesZNF143 protein, humanTrans-Activators

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Shenzhen Hospital of Traditional Chinese Medicine, Shenzhen, China.
  • The Fourth Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Shenzhen Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Traditional Chinese Medicine, Shenzhen, China.
  • Department of Hematology and Oncology, Third People's Hospital of Zigong, Zigong, China.
  • Department of Cardiopulmonary Rehabilitation and Sleep Medicine, First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China.

Förderung

  • Sanming Project of Medicine in Shenzhen
  • "Zhaoyang Talents Project" of Guangdong Provincial Hospital of Chinese Medicine
  • “Zhaoyang Talents Project” of Guangdong Provincial Hospital of Chinese Medicine

Zitieren

APA

Lv, M., Chen, X., Wang, Y., Yang, Q., Lv, Y., Xie, W., & Cai, J. (2026). A plant alkaloid lycorine inhibits non-small cell lung cancer cell proliferation, metastasis, glycolysis and promotes ferroptosis through the ZNF143/SPC25 axis. Journal of Natural Medicines, 80(3), 530-540. https://doi.org/10.1007/s11418-025-01966-8

Vancouver

Lv M, Chen X, Wang Y, Yang Q, Lv Y, Xie W, et al. A plant alkaloid lycorine inhibits non-small cell lung cancer cell proliferation, metastasis, glycolysis and promotes ferroptosis through the ZNF143/SPC25 axis. Journal of Natural Medicines. 2026;80(3):530-540. doi:10.1007/s11418-025-01966-8

BibTeX
@article{Lv2026,
  author = {Lv, Meng and Chen, Xiangrui and Wang, Yaqiong and Yang, Qiting and Lv, Yongbiao and Xie, Wei and Cai, Junxiang},
  title = {A plant alkaloid lycorine inhibits non-small cell lung cancer cell proliferation, metastasis, glycolysis and promotes ferroptosis through the ZNF143/SPC25 axis},
  journal = {Journal of Natural Medicines},
  year = {2026},
  volume = {80},
  number = {3},
  pages = {530--540},
  doi = {10.1007/s11418-025-01966-8}
}
Kostenlos starten →